Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;56(3):293-300.
doi: 10.1007/s00120-016-0292-1.

[Pathogenesis of urological complications after radiation therapy]

[Article in German]
Affiliations
Review

[Pathogenesis of urological complications after radiation therapy]

[Article in German]
Y Tolkach et al. Urologe A. 2017 Mar.

Abstract

Radiation therapy is a treatment modality that is often used in the uro-oncological setting. The common indication for the radiation therapy in the urological sphere is prostate cancer, whether it is used primarily as a radical approach, or postoperatively as adjuvant or salvage therapy. All urological organs are sensitive to radiation injury with the urinary bladder being the most susceptible with a typical cascade including acute and late changes, arising in the dose-dependent manner. The common indication for radiation therapy in urology is prostate cancer, which collaterally affects the urinary bladder and rarely urethra (especially the bulbo-membranous urethra). Ureteral damage and stricture formation is almost always restricted to the cases of intraoperative therapy and external beam radiation therapy for other urological malignancies (gynecological organs, rectum, retroperitoneal soft tissue tumors) and should not be underestimated. Postradiotherapeutic tissue changes, especially of the prostate, can cause difficulties for pathologists and urologists with regard to diagnosis of prostate cancer recurrence and salvage therapy.

Keywords: Cell cycle; Prostate; Radiation dosage; Radiation therapy; Urinary bladder.

PubMed Disclaimer

Similar articles

References

    1. J Urol. 2007 Aug;178(2):529-34; discussion 534 - PubMed
    1. Nat Rev Urol. 2010 Apr;7(4):206-14 - PubMed
    1. Am J Clin Oncol. 2014 Jun;37(3):297-304 - PubMed
    1. Am J Surg Pathol. 2004 Jul;28(7):909-13 - PubMed
    1. Surg Oncol Clin N Am. 2003 Oct;12(4):925-42 - PubMed

MeSH terms

LinkOut - more resources